更正：预测性肿瘤学第一季度每股收益（0.34）同比上涨，销售额（同比）4.86万美元，上涨110.31万美元

Predictive Oncology (NASDAQ: POAI) reported quarterly losses of $(0.34) per share. This is a 67.31 percent increase over losses of $(1.04) per share from the same period last year. The company reported $110.31 thousand in sales this quarter. This is a 2.17K percent increase over sales of $4.86 thousand the same period last year.